Healthcare Services

Food Allergy Treatment Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The Food Allergy Treatment Market By 2030 Based On Its 2026 Value?

The food allergy treatment market size has experienced swift expansion in recent years. Projections indicate it will increase from $7.6 billion in 2025 to $8.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.8%. This historical growth is largely attributable to factors such as an increase in food allergy prevalence, the availability of antihistamines, the wider adoption of epinephrine therapy, higher allergy diagnosis rates, and the continuous development of clinical guidelines.

The food allergy treatment market size is poised for significant expansion in the coming years. Its valuation is projected to reach $12.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period can be attributed to advancements in oral immunotherapy, the expansion of biologic treatments, an increase in pediatric allergy care, the growing demand for long-term allergy management, and improved healthcare access. Major trends expected in this period include the rising adoption of immunotherapy-based treatments, an increase in the use of epinephrine auto-injectors, a growing emphasis on preventive allergy management, the broadening of personalized allergy treatment plans, and heightened awareness of food allergy conditions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16684&type=smp

Which Strategic Drivers Are Supporting The Food Allergy Treatment Market Development?

The expansion of the food allergy treatment market is anticipated to be fueled by the rising incidence of food adulteration going forward. Food adulteration involves the deliberate modification of food items, such as incorporating substandard, detrimental, or unapproved components, or extracting essential ingredients. This is typically done to boost volume or improve aesthetic appeal, frequently compromising the product’s quality and safety. Various factors contribute to the rise in food adulteration, including the pursuit of economic benefits, intricate supply chains, insufficient regulatory oversight, advancements in technology, consumer demand for convenience, globalized markets, environmental influences, consumer understanding, profit motives, and lax enforcement of existing rules. A key driver behind the escalation of food adulteration is the growing consumer desire for more affordable goods, which prompts manufacturers to reduce expenses and optimize profits through morally questionable methods. The risk of allergic reactions can escalate due to food adulteration, as it may introduce allergens into food items or undermine the overall safety and integrity of the food supply. Illustratively, in 2023, the FDA CORE Network, a U.S.-based government agency, reported that its team assessed 69 incidents, addressed 25, and issued 10 public health warnings. This stands in comparison to 2022, when they evaluated 65 incidents, responded to 28, and released 11 advisories. Consequently, the surge in food adulteration is a significant impetus behind the expansion of the food allergy treatment market.

What Key Segment Areas Are Included In The Food Allergy Treatment Market Assessment?

The food allergy treatment market covered in this report is segmented –

1) By Drug Type: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anti-Cholinergic, Immuno-Modulators, Epinephrine, Immunotherapy

2) By Route Of Administration: Parenteral, Oral

3) By Allergen Type: Dairy Products, Poultry Product, Tree Nuts, Peanuts, Shellfish, Wheat, Soys, Other Allergens

4) By End-Use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses

Subsegments:

1) By Antihistamines: Oral Antihistamines, Topical Antihistamines, Intranasal Antihistamines

2) By Decongestants: Oral Decongestants, Nasal Decongestants

3) By Corticosteroids: Oral Corticosteroids, Topical Corticosteroids, Intranasal Corticosteroids

4) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil

5) By Leukotriene Inhibitors: Montelukast, Zafirlukast

6) By Nasal Anti-Cholinergic: Ipratropium Bromide

7) By Immuno-Modulators: Omalizumab, Dupilumab

8) By Epinephrine: Injectable Epinephrine, Auto-Injectors

9) By Immunotherapy: Oral Immunotherapy (OIT), Sublingual Immunotherapy (SLIT), Epicutaneous Immunotherapy (EPIT)

Which Trends Are Affecting The Food Allergy Treatment Market Framework?

Leading companies within the food allergy treatment market are actively developing innovative therapies, such as monoclonal antibodies, to target the fundamental mechanisms of food allergies and provide more effective solutions for patients. Monoclonal antibodies present a promising strategy for managing food allergies by specifically targeting components of the immune system involved in allergic reactions, thereby offering more precise and efficacious treatments for individuals. For example, in February 2024, Novartis AG, a pharmaceutical company based in Switzerland, secured FDA approval for Xolair (omalizumab) to diminish IgE-mediated food allergies. This humanized monoclonal antibody, administered subcutaneously, functions by inhibiting the binding of IgE antibodies, consequently reducing the release of chemicals responsible for allergy symptoms. The FDA approval is substantiated by positive results from the Phase III OUtMATCH study, which revealed that a significantly greater proportion of food allergy patients, including those as young as 1 year, treated with Xolair were able to tolerate small amounts of peanut, milk, egg, and cashews without an allergic reaction, when compared to the placebo group.

Which Companies Are Engaged In The Food Allergy Treatment Market Environment?

Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation

Access The Complete Food Allergy Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/food-allergy-treatment-global-market-report

Which Area Represents The Largest Portion Of The Food Allergy Treatment Market?

North America was the largest region in the food allergy treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Food Allergy Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16684&type=smp

Browse Through More Reports Similar to the Global Food Allergy Treatment Market 2026, By The Business Research Company

Allergy Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

Peanut Allergy Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peanut-allergy-treatment-global-market-report

Allergy Immunotherapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795